Aflibercept, sold under the brand names Eylea and Zaltrap among others, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. [20][21] It was developed by Regeneron …

Nov 20, 2025 · Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor that is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a …

Nov 1, 2025 · Aflibercept injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurred vision or blindness.

EYLEA ® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known …

Aug 5, 2024 · Find patient medical information for Aflibercept (Eylea) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Aug 19, 2025 · Aflibercept is a humanized recombinant fusion protein that functions as a soluble decoy for VEGF receptors, also known as "VEGF trap," which is designed to inhibit the predominant …

Dec 22, 2025 · A trio of retina specialists recently reviewed the clinical benefits of aflibercept 8 mg, including its extended dosing intervals, improved patient satisfaction, and enhanced treatment …

What is aflibercept? Aflibercept is a medicine injected into the eye. It is used to treat: Neovascular (wet) age-related macular degeneration Macular oedema secondary to retinal vein occlusion Diabetic …

Once absorbed into the systemic circulation, aflibercept presents in the plasma as free aflibercept (unbound to VEGF) and a more predominant stable inactive form with circulating endogenous VEGF …

AFLIBERCEPT (a FLIB er sept) treats eye conditions, such as macular degeneration, macular edema, and retinopathy. It works by slowing the growth of abnormal new blood vessels in the eye.